Article
An Immune Gene Signature for Prediction of Overall Survival and Response to Immune Checkpoint Inhibitors Therapy in Patients with Lung Adenocarcinoma
2022-01-31
Abstract excerpt
Lung adenocarcinoma is one of the most common malignant tumors worldwide. The purpose of this study was to construct a stable immune gene signature for prediction of prognosis (IGSPP) and response to immune checkpoint inhibitors (ICIs) therapy in LUAD patients. Five genes were screened by weighted gene coexpression network analysis, Cox regression and LASSO regression analyses and were used to construct the IGSPP....
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a3d28d22-7024-5d1f-a23e-0ba1b8adbd86
- DOI
- 10.21203/rs.3.rs-1264781/v1
